Search by Drug Name or NDC

    NDC 52652-5001-01 Katerzia 1 mg/mL Details

    Katerzia 1 mg/mL

    Katerzia is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is AMLODIPINE BENZOATE.

    Product Information

    NDC 52652-5001
    Product ID 52652-5001_78965c75-1ba7-48f0-bc14-029d5bb34f88
    Associated GPIs 34000003081820
    GCN Sequence Number 079995
    GCN Sequence Number Description amlodipine benzoate ORAL SUSP 1 MG/ML ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 46652
    HICL Sequence Number 045864
    HICL Sequence Number Description AMLODIPINE BENZOATE
    Brand/Generic Brand
    Proprietary Name Katerzia
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 1
    Active Ingredient Units mg/mL
    Substance Name AMLODIPINE BENZOATE
    Labeler Name Azurity Pharmaceuticals, Inc.
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211340
    Listing Certified Through 2024-12-31

    Package

    NDC 52652-5001-01 (52652500101)

    NDC Package Code 52652-5001-1
    Billing NDC 52652500101
    Package 1 BOTTLE in 1 CARTON (52652-5001-1) / 150 mL in 1 BOTTLE
    Marketing Start Date 2019-08-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 3.74062
    Pricing Unit ML
    Effective Date 2024-01-01
    NDC Description KATERZIA 1 MG/ML SUSPENSION
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis